Human Papillomavirus (HPV) Vaccines

1

Review clinical trials related to Human Papillomavirus (HPV) Vaccines. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Maximizing HPV Vaccination: Real-time Reminders, Guidance, and Recommendations - Part 4: Feasibility Trial

Human papillomavirus (HPV) vaccines have potential to prevent an average of 26,900 cancer cases each year in the United States, but vaccine coverage rates remain low. The study team has developed an electronic application (app), Protect Me 4, to help parents and providers assess and have more productive conversations about needed vaccines. The specific aims of this study are to: (1) evaluate the feasibility of implementing Protect Me 4, and (2) estimate preliminary efficacy of Protect Me 4 to increase HPV vaccine initiation (receipt of first dose).

Participants needed: 1,296
Trial details
Age: 18-99Biological sex: AllType: InterventionalSponsor: University of FloridaUpdated: Sep 14, 2026Locations: 1
Eligibility criteria

Must be parent of an adolescent aged 11-12 years old. [+3]

Adolescents out of the age range for participation [+2]